Sunshine Biopharma Inc
NASDAQ:SBFM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.22
3.46
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Sunshine Biopharma Inc
|
Revenue
|
36.3m
USD
|
|
Cost of Revenue
|
-24.2m
USD
|
|
Gross Profit
|
12.1m
USD
|
|
Operating Expenses
|
-17.5m
USD
|
|
Operating Income
|
-5.4m
USD
|
|
Other Expenses
|
-873.9k
USD
|
|
Net Income
|
-6.3m
USD
|
Income Statement
Sunshine Biopharma Inc
| Jul-2008 | Oct-2008 | Jan-2009 | Apr-2009 | Jul-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+18%
|
0
-15%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+1 500%
|
0
+228%
|
0
+100%
|
0
+52%
|
0
+38%
|
0
+22%
|
0
+31%
|
0
+42%
|
0
+38%
|
0
+24%
|
0
+33%
|
0
+36%
|
0
+31%
|
0
+20%
|
4
+785%
|
9
+110%
|
15
+59%
|
20
+40%
|
24
+18%
|
27
+11%
|
30
+14%
|
33
+8%
|
35
+6%
|
36
+4%
|
36
+0%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(3)
|
(6)
|
(9)
|
(13)
|
(16)
|
(18)
|
(21)
|
(23)
|
(24)
|
(25)
|
(24)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+1 600%
|
0
+118%
|
0
+170%
|
0
+72%
|
0
+49%
|
0
+34%
|
0
+34%
|
0
+30%
|
0
+41%
|
0
+24%
|
0
+6%
|
0
+37%
|
0
+27%
|
0
+19%
|
2
+640%
|
3
+104%
|
5
+54%
|
7
+36%
|
8
+15%
|
9
+6%
|
9
+5%
|
10
+9%
|
11
+5%
|
11
+4%
|
12
+10%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(0)
|
(0)
|
1
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(10)
|
(31)
|
(15)
|
(16)
|
(13)
|
(13)
|
(14)
|
(15)
|
(16)
|
(17)
|
(18)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(0)
|
(0)
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(9)
|
(12)
|
(13)
|
(15)
|
(11)
|
(11)
|
(12)
|
(13)
|
(15)
|
(16)
|
(17)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
+25%
|
(0)
-8%
|
(0)
+8%
|
(0)
-19%
|
(0)
-40%
|
(2)
-7 018%
|
(2)
-4%
|
(0)
+72%
|
(0)
-6%
|
1
N/A
|
1
-4%
|
(1)
N/A
|
(1)
+3%
|
(1)
-15%
|
(1)
-36%
|
(1)
+24%
|
(1)
-144%
|
(2)
-4%
|
(1)
+11%
|
(2)
-35%
|
(1)
+29%
|
(2)
-35%
|
(2)
-6%
|
(1)
+20%
|
(1)
+19%
|
(1)
+22%
|
(1)
+18%
|
(1)
+16%
|
(1)
+6%
|
(1)
-19%
|
(1)
-3%
|
(1)
-25%
|
(1)
-5%
|
(1)
+1%
|
(1)
+2%
|
(1)
+19%
|
(1)
-4%
|
(1)
-13%
|
(1)
-19%
|
(1)
+3%
|
(1)
+3%
|
(1)
+48%
|
(0)
+14%
|
(1)
-18%
|
(0)
+10%
|
(1)
-14%
|
(0)
+22%
|
(1)
-34%
|
(2)
-215%
|
(2)
-14%
|
(3)
-21%
|
(2)
+3%
|
(2)
+2%
|
(3)
-13%
|
(4)
-45%
|
(9)
-121%
|
(28)
-218%
|
(10)
+65%
|
(9)
+10%
|
(5)
+45%
|
(4)
+10%
|
(5)
-6%
|
(5)
-7%
|
(6)
-18%
|
(6)
+2%
|
(5)
+5%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(7)
|
(8)
|
(11)
|
(10)
|
(5)
|
(3)
|
1
|
(18)
|
0
|
(18)
|
(18)
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
+9%
|
(0)
-5%
|
(0)
+33%
|
(0)
-26%
|
(0)
-271%
|
(2)
-1 705%
|
(2)
-10%
|
(1)
+71%
|
(1)
+7%
|
1
N/A
|
1
+4%
|
(1)
N/A
|
(1)
+2%
|
(1)
-16%
|
(1)
-41%
|
(1)
+21%
|
(2)
-203%
|
(2)
-2%
|
(2)
+9%
|
(2)
-25%
|
(1)
+41%
|
(2)
-48%
|
(2)
-5%
|
(2)
+15%
|
(2)
+8%
|
(1)
+20%
|
(1)
+6%
|
(2)
-23%
|
(2)
-1%
|
(2)
+2%
|
(3)
-84%
|
(3)
-16%
|
(3)
+3%
|
(3)
0%
|
(2)
+42%
|
(1)
+47%
|
(1)
-5%
|
(1)
-15%
|
(2)
-61%
|
(2)
-6%
|
(2)
+2%
|
(2)
+25%
|
(1)
+36%
|
(1)
-7%
|
(1)
+10%
|
(2)
-80%
|
(2)
-20%
|
(3)
-33%
|
(9)
-219%
|
(11)
-22%
|
(14)
-31%
|
(12)
+12%
|
(7)
+40%
|
(5)
+31%
|
(3)
+50%
|
(27)
-934%
|
(27)
-2%
|
(27)
-1%
|
(26)
+3%
|
(4)
+84%
|
(4)
+10%
|
(4)
-1%
|
(4)
-10%
|
(5)
-31%
|
(5)
+1%
|
(6)
-21%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(1)
|
(1)
|
1
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(9)
|
(11)
|
(14)
|
(12)
|
(7)
|
(5)
|
(3)
|
(27)
|
(27)
|
(28)
|
(27)
|
(5)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
+9%
|
(0)
-5%
|
(0)
+33%
|
(0)
-26%
|
(0)
-271%
|
(2)
-1 705%
|
(2)
-10%
|
(1)
+71%
|
(1)
+7%
|
1
N/A
|
1
+4%
|
(1)
N/A
|
(1)
+2%
|
(1)
-16%
|
(1)
-41%
|
(1)
+21%
|
(2)
-203%
|
(2)
-2%
|
(2)
+9%
|
(2)
-25%
|
(1)
+41%
|
(2)
-48%
|
(2)
-5%
|
(2)
+15%
|
(2)
+8%
|
(1)
+20%
|
(1)
+6%
|
(2)
-23%
|
(2)
-1%
|
(2)
+2%
|
(3)
-84%
|
(3)
-16%
|
(3)
+3%
|
(3)
0%
|
(2)
+42%
|
(1)
+47%
|
(1)
-7%
|
(1)
-14%
|
(2)
-60%
|
(2)
-6%
|
(2)
+3%
|
(2)
-3%
|
(2)
+26%
|
(2)
-4%
|
(2)
+7%
|
(2)
-13%
|
(2)
-20%
|
(3)
-33%
|
(9)
-219%
|
(11)
-22%
|
(14)
-31%
|
(12)
+12%
|
(7)
+40%
|
(5)
+31%
|
(3)
+50%
|
(27)
-943%
|
(27)
-2%
|
(28)
-1%
|
(27)
+3%
|
(5)
+83%
|
(4)
+9%
|
(4)
+10%
|
(4)
-15%
|
(5)
-21%
|
(5)
+2%
|
(6)
-25%
|
|
| EPS (Diluted) |
-26 506.18
N/A
|
-23 888.37
+10%
|
-25 190.46
-5%
|
-16 879.42
+33%
|
-21 316.57
-26%
|
-29 649.04
-39%
|
-449 162.38
-1 415%
|
-492 390.93
-10%
|
-143 993.42
+71%
|
-139 978.82
+3%
|
282 068.75
N/A
|
294 992.35
+5%
|
-144 085.94
N/A
|
-136 622.49
+5%
|
-149 260.4
-9%
|
-178 963.22
-20%
|
-113 784.08
+36%
|
-333 852.6
-193%
|
-338 212.78
-1%
|
-303 233.33
+10%
|
-359 807.96
-19%
|
-200 975.15
+44%
|
-284 892.57
-42%
|
-292 992.69
-3%
|
-233 982.87
+20%
|
-206 048.03
+12%
|
-124 535.97
+40%
|
-103 881.82
+17%
|
-108 140.21
-4%
|
-79 947.39
+26%
|
-70 936.67
+11%
|
-30 198.99
+57%
|
-65 839.44
-118%
|
-33 871
+49%
|
-33 912
0%
|
-19 532
+42%
|
-9 535.95
+51%
|
-11 101
-16%
|
-12 689.99
-14%
|
-20 289.99
-60%
|
-14 034.04
+31%
|
-10 465.49
+25%
|
-7 199
+31%
|
-4 005.74
+44%
|
-1 659.99
+59%
|
-816.84
+51%
|
-227.07
+72%
|
-149.77
+34%
|
-278.39
-86%
|
-405.24
-46%
|
-453.83
-12%
|
-558.55
-23%
|
-478.3
+14%
|
-142.07
+70%
|
-32.47
+77%
|
-13.57
+58%
|
-175.94
-1 197%
|
-123.46
+30%
|
-108.77
+12%
|
-104.19
+4%
|
-18.54
+82%
|
-6.37
+66%
|
-73.99
-1 062%
|
-3.33
+95%
|
-7.32
-120%
|
-1.86
+75%
|
-1.4
+25%
|
|